Literatures have also reported modulation of the TME by neoadjuvant therapy in locally advanced ESCC, showing enhanced infiltrations of macrophages and PD-L1 + cells in non-pCR patients [25, 26]. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.